Replies to post #155310 on Cytodyn Inc (CYDY)

[LifeLongLearner]

Until we see the final results, no one knows the if these numbers will hold.

The DSMC said lenzilumab had 37% efficacy during the interim analysis. The 37% efficacy was with all of the patients, not a 16% slice of patients like leronlimab.